4qms › Citations

Discovery of Diverse Small-Molecule Inhibitors of Mammalian Sterile20-like Kinase 3 (MST3).

Olesen SH, Zhu JY, Martin MP, Schönbrunn E
ChemMedChem 11 1137-44 (2016)
Related entries: 4qml, 4qmm, 4qmn, 4qmo, 4qmp, 4qmq, 4qmt, 4qmu, 4qmv, 4qmw, 4qmx, 4qmy, 4qmz, 4qna, 4qo9

Cited: 18 times
EuropePMC logo PMID: 27135311

Abstract

Increasing evidence suggests key roles for members of the mammalian Sterile20-like (MST) family of kinases in many aspects of biology. MST3 is a member of the STRIPAK complex, the deregulation of which has recently been associated with cancer cell migration and metastasis. Targeting MST3 with small-molecule inhibitors may be beneficial for the treatment of certain cancers, but little information exists on the potential of kinase inhibitor scaffolds to engage with MST3. In this study we screened MST3 against a library of 277 kinase inhibitors using differential scanning fluorimetry and confirmed 14 previously unknown MST3 inhibitors by X-ray crystallography. These compounds, of which eight are in clinical trials or FDA approved, comprise nine distinct chemical scaffolds that inhibit MST3 enzymatic activity with IC50 values between 0.003 and 23 μm. The structure-activity relationships explain the differential inhibitory activity of these compounds against MST3 and the structural basis for high binding potential, the information of which may serve as a framework for the rational design of MST3-selective inhibitors as potential therapeutics and to interrogate the function of this enzyme in diseased cells.

Articles - 4qms mentioned but not cited (4)

  1. Analysis of tractable allosteric sites in G protein-coupled receptors. Wakefield AE, Mason JS, Vajda S, Keserű GM. Sci Rep 9 6180 (2019)
  2. An integrated approach towards the development of novel antifungal agents containing thiadiazole: synthesis and a combined similarity search, homology modelling, molecular dynamics and molecular docking study. Er M, Abounakhla AM, Tahtaci H, Bawah AH, Çınaroğlu SS, Onaran A, Ece A. Chem Cent J 12 121 (2018)
  3. Vibrational analysis of acetylcholine binding to the M2 receptor. Suzuki K, Katayama K, Sumii Y, Nakagita T, Suno R, Tsujimoto H, Iwata S, Kobayashi T, Shibata N, Kandori H. RSC Adv 11 12559-12567 (2021)
  4. Therapeutic targets and signaling mechanisms of dasatinib activity against radiation skin ulcer. Su W, Chen X, Zhang W, Li D, Chen X, Yu D. Front Public Health 10 1031038 (2022)


Reviews citing this publication (2)

  1. Emerging Pharmacologic Targets in Cerebral Cavernous Malformation and Potential Strategies to Alter the Natural History of a Difficult Disease: A Review. Chohan MO, Marchiò S, Morrison LA, Sidman RL, Cavenee WK, Dejana E, Yonas H, Pasqualini R, Arap W. JAMA Neurol 76 492-500 (2019)
  2. Molecular mechanisms involved in regulating protein activity and biological function of MST3. Qiu J, Xiong J, Jiang L, Wang X, Zhang K, Yu H. Cell Div 18 8 (2023)

Articles citing this publication (12)

  1. Structural Basis of Wee Kinases Functionality and Inactivation by Diverse Small Molecule Inhibitors. Zhu JY, Cuellar RA, Berndt N, Lee HE, Olesen SH, Martin MP, Jensen JT, Georg GI, Schönbrunn E. J Med Chem 60 7863-7875 (2017)
  2. Genomic and transcriptomic characterisation of undifferentiated pleomorphic sarcoma of bone. Ali NM, Niada S, Brini AT, Morris MR, Kurusamy S, Alholle A, Huen D, Antonescu CR, Tirode F, Sumathi V, Latif F. J Pathol 247 166-176 (2019)
  3. Calm the raging hormone - A new therapeutic strategy involving progesterone-signaling for hemorrhagic CCMs. Zhang J, Abou-Fadel JS. Vessel Plus 5 48 (2021)
  4. The oncogenic role of MST3 in human gastric cancer. Lee KT, Chang CL, Li CY, Song H, Shan YS, Lai MD. Am J Cancer Res 8 2130-2139 (2018)
  5. Dasatinib-SIK2 Binding Elucidated by Homology Modeling, Molecular Docking, and Dynamics Simulations. Shi M, Wang L, Li P, Liu J, Chen L, Xu D. ACS Omega 6 11025-11038 (2021)
  6. iVS analysis to evaluate the impact of scaffold diversity in the binding to cellular targets relevant in cancer. Cilibrizzi A, Floresta G, Abbate V, Giovannoni MP. J Enzyme Inhib Med Chem 34 44-50 (2019)
  7. Molecular dynamics simulations of the conformational plasticity in the active pocket of salt-inducible kinase 2 (SIK2) multi-state binding with bosutinib. Shi M, Wang L, Liu K, Chen Y, Hu M, Yang L, He J, Chen L, Xu D. Comput Struct Biotechnol J 20 2574-2586 (2022)
  8. Anti-proliferative Activity of Piper trioicum Leaf Essential Oil Based on Phytoconstituent Analysis, Molecular Docking and in silico ADMET Approaches. Jena S, Ray A, Sahoo A, Das PK, Kamila PK, Kar SK, Nayak S, Panda PC. Comb Chem High Throughput Screen 26 183-190 (2023)
  9. Dimerization and autophosphorylation of the MST family of kinases are controlled by the same set of residues. Weingartner KA, Tran T, Tripp KW, Kavran JM. Biochem J 480 1165-1182 (2023)
  10. TWN-RENCOD: A novel method for protein binding site comparison. Choi KE, Balupuri A, Kang NS. Comput Struct Biotechnol J 21 425-431 (2023)
  11. Discovery of Kinase and Carbonic Anhydrase Dual Inhibitors by Machine Learning Classification and Experiments. Kim MJ, Pandit S, Jee JG. Pharmaceuticals (Basel) 15 236 (2022)
  12. Regulatory spine RS3 residue of protein kinases: a lipophilic bystander or a decisive element in the small-molecule kinase inhibitor binding? Shevchenko E, Pantsar T. Biochem Soc Trans 50 633-648 (2022)


Quick links